Home / Drug API Insights / Natpara - API Insight, 2017
Natpara - API Insight, 2017
Date: Jan, 2018
Type: Pharmaceutical Industry Report
Pages: 30
Geography: Global
Delivery Timeline: 48 Hours
SKU: DIDA0103
"Natpara - API Insight, 2018" report by DelveInsight provides product and API manufacturers details across US, Europe, China and India for Natpara . It includes Natpara overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities. It further provides Natpara s patents information (US & EU). It also features the historical and forecasted sales of Natpara till 2020. The report also highlights Natpara s market competition and emerging therapies which are in the same space as Natpara .
Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsights team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.
Scope of the report
• A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
• Patent information around Natpara in United States (US) and Europe (EU) has been highlighted
• API manufacturers for Natpara in United States, Europe, China and India
• The report contains historical and forecasted sales for Natpara till 2020
• Enlists the market competition and emerging therapies in the space where Natpara operates
Reasons to Buy
• Establish a comprehensive understanding of the drug, Natpara
• Access to Natpara s API manufacturers details to devise API procurement strategy for generic development
• Plan generic developmental timelines around Natpara s patents for the major markets- US and EU
• Understand Natpara s current and future growth through its historical and forecasted sales
• Identify the current in-market competitors for Natpara
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify the emerging players and their products operating in the same space as Natpara
Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsights team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.
Scope of the report
• A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
• Patent information around Natpara in United States (US) and Europe (EU) has been highlighted
• API manufacturers for Natpara in United States, Europe, China and India
• The report contains historical and forecasted sales for Natpara till 2020
• Enlists the market competition and emerging therapies in the space where Natpara operates
Reasons to Buy
• Establish a comprehensive understanding of the drug, Natpara
• Access to Natpara s API manufacturers details to devise API procurement strategy for generic development
• Plan generic developmental timelines around Natpara s patents for the major markets- US and EU
• Understand Natpara s current and future growth through its historical and forecasted sales
• Identify the current in-market competitors for Natpara
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify the emerging players and their products operating in the same space as Natpara
1. Report Introduction
2. Natpara Overview
• Product Description
• Mechanism of Action
• Dosage and Administration
• Pharmacodynamic Properties
• Pharmacokinetic Properties
• Safety and Efficacy of Natpara
• Clinical Trial Description
• Adverse Reactions
• Product Development Activities
3. Product Details
• United States
• Europe
4. Natpara Global Sales Assessment
• Historical Global Sales
• Forecasted Global Sales
5. Patent Details
6. Global API Manufacturers Assessment
• United States
• Europe
• China
• India
7. Market Competitors
8. Emerging Therapies
9. Appendix
• Methodology
• Consulting Services
• About DelveInsight
• Contact Us
• Disclaimer
Note: Certain sections of the table of contents would vary according to the availability of information
2. Natpara Overview
• Product Description
• Mechanism of Action
• Dosage and Administration
• Pharmacodynamic Properties
• Pharmacokinetic Properties
• Safety and Efficacy of Natpara
• Clinical Trial Description
• Adverse Reactions
• Product Development Activities
3. Product Details
• United States
• Europe
4. Natpara Global Sales Assessment
• Historical Global Sales
• Forecasted Global Sales
5. Patent Details
6. Global API Manufacturers Assessment
• United States
• Europe
• China
• India
7. Market Competitors
8. Emerging Therapies
9. Appendix
• Methodology
• Consulting Services
• About DelveInsight
• Contact Us
• Disclaimer
Note: Certain sections of the table of contents would vary according to the availability of information
Table 1: Natpara Description
Table 2: Natpara Product Details, United States
Table 3: Natpara Product Details, Europe
Table 4: Natpara , Historical Global Sales till 2017 (in million USD)
Table 5: Natpara , Forecasted Global Sales from 2018-2020 (in million USD)
Table 6: Patent Details: Natpara
Table 7: API Manufacturers Region wise
Table 8: API Manufacturers for United States
Table 9: API Manufacturers for Europe
Table 10: API Manufacturers for China
Table 11: API Manufacturers for India
Table 12: Natpara Market Competitors
Table 13: Emerging Therapies
Table 2: Natpara Product Details, United States
Table 3: Natpara Product Details, Europe
Table 4: Natpara , Historical Global Sales till 2017 (in million USD)
Table 5: Natpara , Forecasted Global Sales from 2018-2020 (in million USD)
Table 6: Patent Details: Natpara
Table 7: API Manufacturers Region wise
Table 8: API Manufacturers for United States
Table 9: API Manufacturers for Europe
Table 10: API Manufacturers for China
Table 11: API Manufacturers for India
Table 12: Natpara Market Competitors
Table 13: Emerging Therapies
Figure 1: Natpara
Figure 2: Natpara , Historical Global Sales till 2017 (in million USD)
Figure 3: Natpara , Forecasted Global Sales from 2018-2020 (in million USD)
Figure 4: Patent Details: Natpara
Figure 5: API Manufacturers Region wise
Figure 2: Natpara , Historical Global Sales till 2017 (in million USD)
Figure 3: Natpara , Forecasted Global Sales from 2018-2020 (in million USD)
Figure 4: Patent Details: Natpara
Figure 5: API Manufacturers Region wise
Natpara
Natpara Marketed Drugs Overview
Natpara Market Assessment
Natpara API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
Natpara US DMF
Natpara US Drug Master Files
Natpara Active Substance Master File/ EUDMF
Natpara Generic players
Natpara Patent Expiration
Natpara Patent Exclusivity
Natpara API Manufacturers
Natpara Global Forecasted Sales Figure
Natpara Marketed Drugs Overview
Natpara Market Assessment
Natpara API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
Natpara US DMF
Natpara US Drug Master Files
Natpara Active Substance Master File/ EUDMF
Natpara Generic players
Natpara Patent Expiration
Natpara Patent Exclusivity
Natpara API Manufacturers
Natpara Global Forecasted Sales Figure
